Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    1.15
    -0.01 (-0.86%)
    At close: Jun 05, 2025, 3:59 PM
    1.14
    -0.90%
    After-hours: Jun 05, 2025, 07:30 PM EDT

    Biodexa Pharmaceuticals Statistics

    Share Statistics

    Biodexa Pharmaceuticals has 1.67K shares outstanding. The number of shares has increased by 145.69% in one year.

    Shares Outstanding

    n/a
    		 1.67K

    Shares Change (YoY)

    n/a
    		 145.69%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,107

    FTD / Avg. Volume

    n/a
    		 0.16%

    Short Selling Information

    The latest short interest is 189.59K, so 7.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 189.59K

    Short % of Shares Out

    n/a
    		 7.4%

    Short % of Float

    n/a
    		 7.4%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Biodexa Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 1.75

    Quick Ratio

    n/a
    		 1.75

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 -0.06

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $29,307.69

    Profits Per Employee

    n/a
    		 $-544,538.46

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 n/a

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -406K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -95.39% in the last 52 weeks. The beta is 1.21, so Biodexa Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.21

    52-Week Price Change

    n/a
    		 -95.39%

    50-Day Moving Average

    n/a
    		 1.38

    200-Day Moving Average

    n/a
    		 4.76

    Relative Strength Index (RSI)

    n/a
    		 40.23

    Average Volume (20 Days)

    n/a
    		 2,617,215

    Income Statement

    In the last 12 months, Biodexa Pharmaceuticals had revenue of 381K and earned -7.08M in profits. Earnings per share was -89652.

    Revenue

    n/a
    		 381K

    Gross Profit

    n/a
    		 -3.69M

    Operating Income

    n/a
    		 -8.01M

    Net Income

    n/a
    		 -7.08M

    EBITDA

    n/a
    		 -7.16M

    EBIT

    n/a
    		 -7.44M

    Earnings Per Share (EPS)

    n/a
    		 -89652
    Full Income Statement

    Balance Sheet

    The company has 1.67M in cash and 727K in debt, giving a net cash position of 942K.

    Cash & Cash Equivalents

    n/a
    		 1.67M

    Total Debt

    n/a
    		 727K

    Net Cash

    n/a
    		 942K

    Retained Earnings

    n/a
    		 -150.42M

    Total Assets

    n/a
    		 14.78M

    Working Capital

    n/a
    		 3.78M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.26M and capital expenditures -774K, giving a free cash flow of -13.04M.

    Operating Cash Flow

    n/a
    		 -12.26M

    Capital Expenditures

    n/a
    		 -774K

    Free Cash Flow

    n/a
    		 -13.04M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 -2103.41%

    FCF Margin

    n/a
    		 -3421.26%

    Dividends & Yields

    BDRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BDRX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 4, 2024. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Oct 4, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -16.98

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist